{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:32:06Z","timestamp":1791077526679,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,4,15]],"date-time":"2012-04-15T00:00:00Z","timestamp":1334448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,4,15]],"date-time":"2012-04-15T00:00:00Z","timestamp":1334448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00125-012-2545-x","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T18:14:19Z","timestamp":1334340859000},"page":"1963-1970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study"],"prefix":"10.1007","volume":"55","author":[{"given":"A.","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Corpeleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Postmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. O. B.","family":"Gans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"Hillege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Navis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,15]]},"reference":[{"key":"2545_CR1","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1210\/en.2006-1315","volume":"148","author":"T Aoyagi","year":"2007","unstructured":"Aoyagi T, Birumachi J, Hiroyama M et al (2007) Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology 148:2075\u20132084","journal-title":"Endocrinology"},{"key":"2545_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2337\/diabetes.28.5.503","volume":"28","author":"RL Zerbe","year":"1979","unstructured":"Zerbe RL, Vinicor F, Robertson GL (1979) Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503\u2013508","journal-title":"Diabetes"},{"key":"2545_CR3","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","volume":"26","author":"J Struck","year":"2005","unstructured":"Struck J, Morgenthaler NG, Bergmann A (2005) Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26:2500\u20132504","journal-title":"Peptides"},{"key":"2545_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ki.2009.397","volume":"77","author":"E Meijer","year":"2010","unstructured":"Meijer E, Bakker SJ, Halbesma N, de Jong PE, Struck J, Gansevoort RT (2010) Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int 77:29\u201336","journal-title":"Kidney Int"},{"key":"2545_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112\u2013119","journal-title":"Clin Chem"},{"key":"2545_CR6","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.109.909663","volume":"121","author":"S Enhorning","year":"2010","unstructured":"Enhorning S, Wang TJ, Nilsson PM et al (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121:2102\u20132108","journal-title":"Circulation"},{"key":"2545_CR7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj1780493","volume":"178","author":"CJ Kirk","year":"1979","unstructured":"Kirk CJ, Rodrigues LM, Hems DA (1979) The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes. Biochem J 178:493\u2013496","journal-title":"Biochem J"},{"key":"2545_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/mol.65.3.623","volume":"65","author":"S Oshikawa","year":"2004","unstructured":"Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, Tsujimoto G (2004) Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological\/knockout approach. Mol Pharmacol 65:623\u2013629","journal-title":"Mol Pharmacol"},{"key":"2545_CR9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","volume":"113","author":"A Tanoue","year":"2004","unstructured":"Tanoue A, Ito S, Honda K et al (2004) The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 113:302\u2013309","journal-title":"J Clin Invest"},{"key":"2545_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1113\/jphysiol.2007.136481","volume":"584","author":"Y Fujiwara","year":"2007","unstructured":"Fujiwara Y, Hiroyama M, Sanbe A et al (2007) Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. J Physiol 584:235\u2013244","journal-title":"J Physiol"},{"key":"2545_CR11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1152\/jappl.2001.91.4.1893","volume":"91","author":"NS Stachenfeld","year":"2001","unstructured":"Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP, Keefe DL (2001) Sex differences in osmotic regulation of AVP and renal sodium handling. J Appl Physiol 91:1893\u20131901","journal-title":"J Appl Physiol"},{"key":"2545_CR12","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1210\/jc.2011-1143","volume":"96","author":"LD Simmler","year":"2011","unstructured":"Simmler LD, Hysek CM, Liechti ME (2011) Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab 96:2844\u20132850","journal-title":"J Clin Endocrinol Metab"},{"key":"2545_CR13","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.2337\/diacare.28.10.2525","volume":"28","author":"AH Brantsma","year":"2005","unstructured":"Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT (2005) Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28:2525\u20132530","journal-title":"Diabetes Care"},{"key":"2545_CR14","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1097\/HJH.0b013e328310ddff","volume":"26","author":"JM Halimi","year":"2008","unstructured":"Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, Marre M (2008) Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens 26:2198\u20132206","journal-title":"J Hypertens"},{"key":"2545_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archinte.163.1.93","volume":"163","author":"B Thorand","year":"2003","unstructured":"Thorand B, Lowel H, Schneider A et al (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984\u20131998. Arch Intern Med 163:93\u201399","journal-title":"Arch Intern Med"},{"key":"2545_CR16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/dc06-1693","volume":"30","author":"B Thorand","year":"2007","unstructured":"Thorand B, Baumert J, Kolb H et al (2007) Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA\/KORA Augsburg case-cohort study, 1984\u20132002. Diabetes Care 30:854\u2013860","journal-title":"Diabetes Care"},{"key":"2545_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327\u2013334","journal-title":"JAMA"},{"key":"2545_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/aje\/kwn209","volume":"168","author":"HJ Lambers Heerspink","year":"2008","unstructured":"Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT (2008) Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168:897\u2013905","journal-title":"Am J Epidemiol"},{"key":"2545_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/pds.722","volume":"11","author":"TB Monster","year":"2002","unstructured":"Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT (2002) Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 11:379\u2013384","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2545_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1210\/jc.2008-1426","volume":"94","author":"W Fenske","year":"2009","unstructured":"Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B (2009) Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 94:123\u2013129","journal-title":"J Clin Endocrinol Metab"},{"key":"2545_CR21","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s00125-011-2216-3","volume":"54","author":"A Abbasi","year":"2011","unstructured":"Abbasi A, Corpeleijn E, Postmus D et al (2011) Plasma procalcitonin and risk of type 2 diabetes in the general population. Diabetologia 54:2463\u20132465","journal-title":"Diabetologia"},{"key":"2545_CR22","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.2337\/dc08-0368","volume":"31","author":"B Balkau","year":"2008","unstructured":"Balkau B, Lange C, Fezeu L et al (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31:2056\u20132061","journal-title":"Diabetes Care"},{"key":"2545_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D'Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11\u201321","journal-title":"Stat Med"},{"key":"2545_CR24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-150-11-200906020-00007","volume":"150","author":"NR Cook","year":"2009","unstructured":"Cook NR, Ridker PM (2009) Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 150:795\u2013802","journal-title":"Ann Intern Med"},{"key":"2545_CR25","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2007) Standards of medical care in diabetes\u20142007. Diabetes Care 30 Suppl 1: S4-S41","DOI":"10.2337\/dc07-S004"},{"key":"2545_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/epirev\/mxq019","volume":"33","author":"B Buijsse","year":"2011","unstructured":"Buijsse B, Simmons RK, Griffin SJ, Schulze MB (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33:46\u201362","journal-title":"Epidemiol Rev"},{"key":"2545_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1741-7015-9-103","volume":"9","author":"GS Collins","year":"2011","unstructured":"Collins GS, Mallett S, Omar O, Yu LM (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 9:103","journal-title":"BMC Med"},{"key":"2545_CR28","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/archinte.168.21.2304","volume":"168","author":"K McGeechan","year":"2008","unstructured":"McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY (2008) Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med 168:2304\u20132310","journal-title":"Arch Intern Med"},{"key":"2545_CR29","doi-asserted-by":"publisher","first-page":"E1065","DOI":"10.1210\/jc.2010-2981","volume":"96","author":"S Enhorning","year":"2011","unstructured":"Enhorning S, Struck J, Wirfalt E, Hedblad B, Morgenthaler NG, Melander O (2011) Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 96:E1065\u2013E1072","journal-title":"J Clin Endocrinol Metab"},{"key":"2545_CR30","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1210\/jc.2008-2278","volume":"94","author":"U Saleem","year":"2009","unstructured":"Saleem U, Khaleghi M, Morgenthaler NG et al (2009) Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 94:2558\u20132564","journal-title":"J Clin Endocrinol Metab"},{"key":"2545_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20080140","volume":"116","author":"SS Bhandari","year":"2009","unstructured":"Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL (2009) Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond) 116:257\u2013263","journal-title":"Clin Sci (Lond)"},{"key":"2545_CR32","doi-asserted-by":"publisher","first-page":"e10100","DOI":"10.1371\/journal.pone.0010100","volume":"5","author":"V Salomaa","year":"2010","unstructured":"Salomaa V, Havulinna A, Saarela O et al (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 5:e10100","journal-title":"PLoS One"},{"key":"2545_CR33","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288\u20131299","journal-title":"JAMA"},{"key":"2545_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/clpt.2011.93","volume":"90","author":"C Herder","year":"2011","unstructured":"Herder C, Karakas M, Koenig W (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90:52\u201366","journal-title":"Clin Pharmacol Ther"},{"key":"2545_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2009.04.008","volume":"613","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Aoyagi T, Hiroyama M et al (2009) Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance. Eur J Pharmacol 613:182\u2013188","journal-title":"Eur J Pharmacol"},{"key":"2545_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.psyneuen.2005.07.002","volume":"31","author":"E Kajantie","year":"2006","unstructured":"Kajantie E, Phillips DI (2006) The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31:151\u2013178","journal-title":"Psychoneuroendocrinology"},{"key":"2545_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0165-0173(99)00011-9","volume":"30","author":"ME Rhodes","year":"1999","unstructured":"Rhodes ME, Rubin RT (1999) Functional sex differences (\u2018sexual diergism\u2019) of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res Brain Res Rev 30:135\u2013152","journal-title":"Brain Res Brain Res Rev"},{"key":"2545_CR38","doi-asserted-by":"crossref","unstructured":"Lancet (2011) Taking sex into account in medicine. Lancet 378:1826","DOI":"10.1016\/S0140-6736(11)61795-9"},{"key":"2545_CR39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-8-70","volume":"8","author":"S Oertelt-Prigione","year":"2010","unstructured":"Oertelt-Prigione S, Parol R, Krohn S, Preissner R, Regitz-Zagrosek V (2010) Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines. BMC Med 8:70","journal-title":"BMC Med"}],"updated-by":[{"DOI":"10.1007\/s00125-019-4917-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000}}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-012-2545-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2545-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T18:34:00Z","timestamp":1600281240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-012-2545-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,15]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1007\/s00125-012-2545-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,15]]},"assertion":[{"value":"12 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}